NM_174936.4(PCSK9):c.1807G>A (p.Ala603Thr) AND Familial hypercholesterolemia

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: Jul 25, 2022
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV003581787.1

Allele description [Variation Report for NM_174936.4(PCSK9):c.1807G>A (p.Ala603Thr)]

NM_174936.4(PCSK9):c.1807G>A (p.Ala603Thr)

Gene:

PCSK9:proprotein convertase subtilisin/kexin type 9 [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

1p32.3

Genomic location:

Preferred name:

NM_174936.4(PCSK9):c.1807G>A (p.Ala603Thr)

HGVS:

NC_000001.11:g.55061500G>A
NG_009061.1:g.26954G>A
NM_001407240.1:c.1930G>A
NM_001407241.1:c.1849G>A
NM_001407242.1:c.1810G>A
NM_001407243.1:c.1750G>A
NM_001407244.1:c.1633G>A
NM_001407245.1:c.1615G>A
NM_001407246.1:c.1432G>A
NM_001407247.1:c.1306G>A
NM_174936.4:c.1807G>AMANE SELECT
NP_001394169.1:p.Ala644Thr
NP_001394170.1:p.Ala617Thr
NP_001394171.1:p.Ala604Thr
NP_001394172.1:p.Ala584Thr
NP_001394173.1:p.Ala545Thr
NP_001394174.1:p.Ala539Thr
NP_001394175.1:p.Ala478Thr
NP_001394176.1:p.Ala436Thr
NP_777596.2:p.Ala603Thr
NP_777596.2:p.Ala603Thr
LRG_275t1:c.1807G>A
LRG_275:g.26954G>A
LRG_275p1:p.Ala603Thr
NC_000001.10:g.55527173G>A
NM_174936.3:c.1807G>A
NR_110451.2:n.1414G>A
NR_110451.3:n.2088G>A
NR_176318.1:n.1891G>A
NR_176319.1:n.2366G>A
NR_176320.1:n.2330G>A
NR_176321.1:n.2045G>A
NR_176322.1:n.2000G>A
NR_176323.1:n.1919G>A
NR_176324.1:n.2307G>A

Protein change:

A436T

Links:

dbSNP: rs1245161747

NCBI 1000 Genomes Browser:

rs1245161747

Molecular consequence:

NM_001407240.1:c.1930G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001407241.1:c.1849G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001407242.1:c.1810G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001407243.1:c.1750G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001407244.1:c.1633G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001407245.1:c.1615G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001407246.1:c.1432G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001407247.1:c.1306G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_174936.4:c.1807G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:: Familial hypercholesterolemia
Identifiers:: MONDO: MONDO:0005439; MedGen: C0020445; OMIM: PS143890

Recent activity

Clear Turn Off Turn On

Homo sapiens pro-apoptotic WT1 regulator (PAWR), transcript variant 2, mRNA
Homo sapiens pro-apoptotic WT1 regulator (PAWR), transcript variant 2, mRNA
gi|1890333951|ref|NM_001354732.2|

Nucleotide

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV004358825	Color Diagnostics, LLC DBA Color Health	criteria provided, single submitter (ACMG Guidelines, 2015)	Uncertain significance (Jul 25, 2022)	germline	clinical testing	PubMed (1) [See all records that cite this PMID]

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV004358825

Color Diagnostics, LLC DBA Color Health

criteria provided, single submitter

(ACMG Guidelines, 2015)

Uncertain significance
(Jul 25, 2022)

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]

PMID:: 25741868
PMCID:: PMC4544753

Details of each submission

From Color Diagnostics, LLC DBA Color Health, SCV004358825.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

Description

This missense variant replaces alanine with threonine at codon 603 of the PCSK9 protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has not been reported in individuals affected with familial hypercholesterolemia in the literature. This variant has been identified in 1/232072 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Sep 29, 2024

ClinVar

Relating variation to medicine